Trump administration officials vetoed the FDA's plan to fast-track the review of a psychedelic treatment for severe ...
The American Society of Plastic Surgeons recommended that gender-affirming surgeries be delayed until a patient is at least ...
A new study argues that overlap between advisers and advisees on research topics helps rather than hinders young life scientists.
After discovering a drug he took for restless leg syndrome caused compulsive gambling, J. Aaron Sanders found himself facing “existential questions of free will.” ...
Pfizer reported that its newly acquired weight loss drug showed promise as a monthly treatment, though the field is growing ...
Pfizer disclosed that an experimental weight loss drug, recently picked up through its acquisition of Metsera, hit its marks ...
As we reported here last month, new federal guidelines recommend that women ages 30 to 65 can skip pap smears and do an HPV ...
Pfizer reported weight-loss results for a monthly GLP-1 obesity injection that it acquired as part of the $10 billion Metsera ...
Novo Nordisk on Tuesday said it expects sales and profits to decline this year, as the maker of Wegovy faces growing competition in the obesity market.
At an employee town hall, FDA leaders tried to quell staff concerns about a controversial new program to fast-track certain drugs.
Despite it all, I’m feeling sunny today because the temperature popped above freezing yesterday. Bring it on, February. In this edition: I take a closer look at Doctronic’s hyped “AI doctor” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results